Cargando…
Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels
Small molecule inhibitors of site-specific O-glycosylation by the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-T) family are currently unavailable but hold promise as therapeutics, especially if selective against individual ppGalNAc-T isozymes. To identify a compound targeting the ppGalNA...
Autores principales: | Song, Lina, Linstedt, Adam D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407854/ https://www.ncbi.nlm.nih.gov/pubmed/28362263 http://dx.doi.org/10.7554/eLife.24051 |
Ejemplares similares
-
Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis
por: Nogimori, Kenichi, et al.
Publicado: (2016) -
ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential
por: Wu, Qiong, et al.
Publicado: (2020) -
Making Home Sweet and Sturdy: Toxoplasma gondii ppGalNAc-Ts Glycosylate in Hierarchical Order and Confer Cyst Wall Rigidity
por: Tomita, Tadakimi, et al.
Publicado: (2017) -
ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration
por: Chia, Joanne, et al.
Publicado: (2014) -
Molecular Recognition
of GalNAc in Mucin-Type O-Glycosylation
por: Sanz-Martinez, Ignacio, et al.
Publicado: (2023)